TEMLIMM
Live / Registered — Registered (as of 30 May 2023)
What this means for you
Registered since 30 May 2023. The owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 90864755
- Registration number
- 7064932
- Mark type
- Stylized text
- Filed
- 04 Aug 2021
- Published for opposition
- 02 Aug 2022
- Registered
- 30 May 2023
- Attorney of record
- Cara M. Kearney
Goods and services
- Class 005 — Pharmaceuticals: Pharmaceutical preparations and substances for use in oncology; Pharmaceutical preparations and substances for the treatment of diseases and disorders of the cardiovascular, renal, metabolic, respiratory, nervous, neurological, gastrointestinal and immune systems; Pharmaceutical preparations and substances for the treatment of infection, inflammation, hematological, autoimmune related diseases and disorders; Pharmaceutical preparations and substances, namely, antibodies; vaccines
Owner
- AstraZeneca AB, Södertälje, SE
- AstraZeneca AB, Södertälje, SE
- AstraZeneca AB, Södertälje, SE
Prosecution history
- 30 May 2023 — NOTICE OF REGISTRATION CONFIRMATION EMAILED
- 30 May 2023 — REGISTERED-PRINCIPAL REGISTER
- 21 Apr 2023 — 1(B) BASIS DELETED; PROCEED TO REGISTRATION
- 14 Mar 2023 — NOTICE OF ALLOWANCE CANCELLED
- 21 Apr 2023 — CASE ASSIGNED TO INTENT TO USE PARALEGAL
- 14 Mar 2023 — TEAS DELETE 1(B) BASIS RECEIVED
- 27 Sept 2022 — NOA E-MAILED - SOU REQUIRED FROM APPLICANT
- 02 Aug 2022 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 02 Aug 2022 — PUBLISHED FOR OPPOSITION
- 13 Jul 2022 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
- 29 Jun 2022 — APPROVED FOR PUB - PRINCIPAL REGISTER
- 27 Jun 2022 — TEAS/EMAIL CORRESPONDENCE ENTERED
- 27 Jun 2022 — CORRESPONDENCE RECEIVED IN LAW OFFICE
- 27 Jun 2022 — TEAS RESPONSE TO OFFICE ACTION RECEIVED
- 02 Mar 2022 — NOTIFICATION OF NON-FINAL ACTION E-MAILED